Tender Details

Country: Canada
Summary: Pan-Canadian Academic Detailing Project Evaluation
CAT Ref No: 129126385
Deadline: 03 Dec 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: C-252603320
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Canada's Drug Agency (CDA-AMC) is an independent not-for-profit health care organization that provides Canada's federal, provincial, and territorial health care decision makers with credible, impartial advice and evidence-based information about the effectiveness and efficiency of drugs and health technologies. In addition to evidence and advice, CDA-AMC also provides recommendations and tools. On December 18th, 2023, the federal government announced the creation of Canada's Drug Agency (CDA-AMC) by building on the foundation of CADTH and in partnership with provinces and territories. With the creation of the CDA-AMC, the organization now has emerging areas of focus—in addition to its core work on HTAs and clinical and cost effectiveness of new drugs—which include appropriate prescribing and use, data and analytics, and system coordination. Specific to Appropriate Use (AU), CDA-AMC has been tasked with driving a coordinated approach and a common agenda to improve patient safety and outcomes associated with prescribing and use of medications. To do this, CDA-AMC will finalize a pan-Canadian appropriate prescribing and use strategy and develop a corresponding program.Appropriate use can be defined as follows:Appropriate use is when patients, caregivers, and health care professionals work together to choose safe and effective medications most suited for that person's needs and goals to achieve best health outcomes. This can be subdivided into three main categories consisting of ...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Pan-Canadian Academic Detailing Project Evaluation - Canada Tender

The CANADA'S DRUG AGENCY, a Government sector organization in Canada, has announced a new tender for Pan-Canadian Academic Detailing Project Evaluation. This tender is published on CanadaTenders under CAT Ref No: 129126385 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-03.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.